Who will win India’s weight loss drug war: Wegovy, Mounjaro or Biocon?
India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly planning a global disruption with its generic version. Will India’s obesity crisis create the next big pharma boom? Find out how this battle could change chronic care forever
READ MORE:
Other India Videos
Piyush Goyal: 'Fitch, Moody's and S&P have been unfair to India,' praises CareEdge
India’s ‘eye in the sky’ Netra AEW&C system gets final Ops clearance, boosts air surveillance
UCC in Bengal soon; CM Suvendu Adhikari confirms tabling of Bill in Assembly next week
'Do not test Ram's devotees...': Yogi rips into opposition on Ram Mandir controversy
India's bold Message at UN: 'Peacebuilding must be demand-driven, anchored in national ownership'
